No search results for {{ query }} in products
{{{ product._highlightResult.name.value }}}
{{{ product._snippetResult.description.value }}}...
No search results for {{ query }} in news
{{{ article._highlightResult.title.value }}}
{{{ article._snippetResult.content.body.value }}}...
No search results for {{ query }} in pages
{{{ page._highlightResult.title.value }}}
{{{ page._snippetResult.content.body.value }}}...
Map3® cellular allogeneic bone graft is a natural and safe alternative to autograft that supports the body’s innate healing mechanisms and provides the scaffold and signals to support the bone healing process. The implant contains the three essential elements of bone formation.
The map3 implant is available in Strips allograft and Chips allograft configurations. The Strips allograft configuration offers unique handling capabilities.
*DBM or representative finished implant is either assayed in vivo in the modified athymic nude rat for bone formation or in vitro for endogenous BMP-2 as a surrogate test marker for osteoinductive potential. Because the combination of various proteins is responsible for osteoinductive potential, DBM when assayed in vitro, is also screened for the presence of BMP-7. Findings from an in vitro assay or animal model are not necessarily predictive of human clinical results.
Regulatory approvals vary by country. Therefore, we kindly ask you to contact the distributor in your region regarding availability of specific products, implants and / or instrumentation in your region.
Implant scaffold components are sterilized through the BioCleanse® Tissue Sterilization Process or Cancelle® SP DBM Sterilization Process as indicated in the labeling.
United States (English)
Europe (English)
Germany (Deutsch)